What does the landscape for biosimilars look like for RA and other connective tissue disorders look like?

What does the landscape for biosimilars look like for RA and other connective tissue disorders look like?

What does the landscape for biosimilars look like for RA and other connective tissue disorders look like?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Joseph Markenson, MD

Joseph Markenson, MD

Department of Rheumatology
Department of Medicine
Hospital for Special Surgery, New York, NY
Attending Physician, Hospital for Special Surgery
Professor of Clinical Medicine, Weill Cornell Medical College